Reviva Pharmaceuticals Holdings, Inc. Stock
Equities
RVPH
US76152G1004
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.37 USD | -.--% | -10.46% | -73.40% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 40.85M |
---|---|---|---|---|---|
Net income 2024 * | -39M | Net income 2025 * | -45M | EV / Sales 2024 * | - |
Net cash position 2024 * | 8.8M | Net cash position 2025 * | 1.2M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.24
x | P/E ratio 2025 * |
-1.55
x | Employees | 15 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 77.05% |
1 week | -10.46% | ||
1 month | -57.98% | ||
3 months | -63.95% | ||
6 months | -64.28% | ||
Current year | -73.40% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 59 | 20-12-10 | |
Narayan Prabhu
DFI | Director of Finance/CFO | 53 | 20-12-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 69 | 20-12-13 | |
Les Funtleyder
BRD | Director/Board Member | 54 | 20-12-13 |
Founder | 59 | 20-12-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 1.37 | -.--% | 91,689 |
24-05-30 | 1.37 | +2.24% | 171,084 |
24-05-29 | 1.34 | -2.90% | 264,559 |
24-05-28 | 1.38 | -9.80% | 950,739 |
24-05-24 | 1.53 | +5.52% | 267,275 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-73.40% | 40.85M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- RVPH Stock